Alto Neuroscience, Inc.'s total assets for Q3 2025 were $147.01M, a decrease of -6.89% from the previous quarter. ANRO total liabilities were $35.45M for the fiscal quarter, a 2.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.